These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 23793099)

  • 1. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.
    Tönjes M; Barbus S; Park YJ; Wang W; Schlotter M; Lindroth AM; Pleier SV; Bai AHC; Karra D; Piro RM; Felsberg J; Addington A; Lemke D; Weibrecht I; Hovestadt V; Rolli CG; Campos B; Turcan S; Sturm D; Witt H; Chan TA; Herold-Mende C; Kemkemer R; König R; Schmidt K; Hull WE; Pfister SM; Jugold M; Hutson SM; Plass C; Okun JG; Reifenberger G; Lichter P; Radlwimmer B
    Nat Med; 2013 Jul; 19(7):901-908. PubMed ID: 23793099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
    Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
    Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma.
    Chaumeil MM; Larson PE; Woods SM; Cai L; Eriksson P; Robinson AE; Lupo JM; Vigneron DB; Nelson SJ; Pieper RO; Phillips JJ; Ronen SM
    Cancer Res; 2014 Aug; 74(16):4247-57. PubMed ID: 24876103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHIP-mediated ubiquitin degradation of BCAT1 regulates glioma cell proliferation and temozolomide sensitivity.
    Lu Z; Wang XY; He KY; Han XH; Wang X; Zhang Z; Qu XH; Chen ZP; Han XJ; Wang T
    Cell Death Dis; 2024 Jul; 15(7):538. PubMed ID: 39075053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.
    Cho HR; Jeon H; Park CK; Park SH; Kang KM; Choi SH
    Sci Rep; 2017 Dec; 7(1):17740. PubMed ID: 29255149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.
    Raffel S; Falcone M; Kneisel N; Hansson J; Wang W; Lutz C; Bullinger L; Poschet G; Nonnenmacher Y; Barnert A; Bahr C; Zeisberger P; Przybylla A; Sohn M; Tönjes M; Erez A; Adler L; Jensen P; Scholl C; Fröhling S; Cocciardi S; Wuchter P; Thiede C; Flörcken A; Westermann J; Ehninger G; Lichter P; Hiller K; Hell R; Herrmann C; Ho AD; Krijgsveld J; Radlwimmer B; Trumpp A
    Nature; 2017 Nov; 551(7680):384-388. PubMed ID: 29144447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.
    Cho HR; Hong B; Kim H; Park CK; Park SH; Park S; Choi SH
    Oncotarget; 2016 Oct; 7(43):69606-69615. PubMed ID: 27626306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired expression of BCAT1 relates to muscle atrophy of mouse model of sarcopenia.
    Ouyang H; Gao X; Zhang J
    BMC Musculoskelet Disord; 2022 May; 23(1):450. PubMed ID: 35562710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
    Zhang L; Han J
    Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-oncology: BCAT1 promotes cell proliferation in aggressive gliomas.
    Bible E
    Nat Rev Neurol; 2013 Aug; 9(8):420. PubMed ID: 23835536
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.
    Panosyan EH; Lasky JL; Lin HJ; Lai A; Hai Y; Guo X; Quinn M; Nelson SF; Cloughesy TF; Nghiemphu PL
    J Neurooncol; 2016 May; 128(1):57-66. PubMed ID: 26922345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCAT1 defines gliomas by IDH status.
    Mayers JR; Vander Heiden MG
    Nat Med; 2013 Jul; 19(7):816-7. PubMed ID: 23836221
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuclear Translocation of LDHA Promotes the Catabolism of BCAAs to Sustain GBM Cell Proliferation through the TxN Antioxidant Pathway.
    Li Z; Gu Z; Wang L; Guan Y; Lyu Y; Zhang J; Wang Y; Wang X; Xiong J; Liu Y
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of BCAT1 Expression is a Sensitive Marker for IDH-Mutant Diffuse Glioma.
    Chen YY; Ho HL; Lin SC; Hsu CY; Ho DM
    Neurosurgery; 2019 Sep; 85(3):335-342. PubMed ID: 30113684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression.
    Qian L; Li N; Lu XC; Xu M; Liu Y; Li K; Zhang Y; Hu K; Qi YT; Yao J; Wu YL; Wen W; Huang S; Chen ZJ; Yin M; Lei QY
    Nat Metab; 2023 Jul; 5(7):1159-1173. PubMed ID: 37337119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma.
    Zhang B; Chen Y; Shi X; Zhou M; Bao L; Hatanpaa KJ; Patel T; DeBerardinis RJ; Wang Y; Luo W
    Cell Mol Life Sci; 2021 Jan; 78(1):195-206. PubMed ID: 32088728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.
    Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
    Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.
    Lenting K; Khurshed M; Peeters TH; van den Heuvel CNAM; van Lith SAM; de Bitter T; Hendriks W; Span PN; Molenaar RJ; Botman D; Verrijp K; Heerschap A; Ter Laan M; Kusters B; van Ewijk A; Huynen MA; van Noorden CJF; Leenders WPJ
    FASEB J; 2019 Jan; 33(1):557-571. PubMed ID: 30001166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma.
    Chen R; Nishimura MC; Kharbanda S; Peale F; Deng Y; Daemen A; Forrest WF; Kwong M; Hedehus M; Hatzivassiliou G; Friedman LS; Phillips HS
    Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14217-22. PubMed ID: 25225364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma.
    McBrayer SK; Mayers JR; DiNatale GJ; Shi DD; Khanal J; Chakraborty AA; Sarosiek KA; Briggs KJ; Robbins AK; Sewastianik T; Shareef SJ; Olenchock BA; Parker SJ; Tateishi K; Spinelli JB; Islam M; Haigis MC; Looper RE; Ligon KL; Bernstein BE; Carrasco RD; Cahill DP; Asara JM; Metallo CM; Yennawar NH; Vander Heiden MG; Kaelin WG
    Cell; 2018 Sep; 175(1):101-116.e25. PubMed ID: 30220459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.